[EN] NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE CARBOXAMIDE D'HÉTÉROARYLE
申请人:HOFFMANN LA ROCHE
公开号:WO2009153182A1
公开(公告)日:2009-12-23
The invention is concerned with novel heteroaryl carboxamide derivatives of Formula (I), wherein (II), m, X, Y, R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.